0      0


100 - Reducing the Overall Risk of Cardiovascular Morbidity and Mortality in the CKD Population


‐ Oct 12, 2014 7:45am

Contact hours available until 10/13/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Commitee disclosures:
• Denise Murcek - Per diem employee, Fresenius Medical Care
• Melissa Nesmith-Vester – Employee, Aegerion
• Elizabeth St. John - Employee, Fresenius Medical Care
• Kyra Trappett – Employee, DaVita

Faculty and speakers have no disclosures to declare.

Commercial Support and Sponsorship:
 Supported by an educational grant from Sanofi Renal

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:
  •     Analyze the laboratory values that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
  •     Discuss the risk factors that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
  •     Recognize effective treatment strategies to minimize hypercalcemia, hyperlipidemia and systemic inflammatory markers in the individual with CKD or incident to hemodialysis/peritoneal dialysis.